Mydaza Injection 100mg

Mydaza Injection 100mg contains azacitidine, an anticancer medicine used under specialist supervision to treat bone-marrow disorders, including myelodysplastic syndromes and forms of acute myeloid leukemia. Azacitidine is a nucleoside metabolic inhibitor that becomes incorporated into genetic material and interferes with abnormal DNA methylation. This action may restore the activity of genes that control cell growth while also damaging dividing abnormal cells, helping the bone marrow produce blood cells. Mydaza is supplied as a powder that must be prepared and administered by healthcare professionals. It may be given by subcutaneous injection or intravenous infusion according to the treatment protocol. The dose, schedule, and number of treatment cycles depend on the patient’s diagnosis, body size, response, blood counts, and health. Adverse effects include nausea, vomiting, diarrhea, constipation, tiredness, injection-site reactions, reduced appetite, fever, and low blood-cell counts. Serious infections or bleeding may occur. Blood counts and kidney and liver function require monitoring. This medicine may harm an unborn baby; contraception is necessary during treatment. Mydaza must only be handled and administered in an oncology setting under the direction of a cancer specialist.

Price: Rs. 40000.00

• Manufacturer
  Al Habib Pharmaceutical
• Generic name
  Azacitidine
• Pack size
  1 Vial injection
• Availability
  In stock
• Prescription required
  Yes